XML 124 R113.htm IDEA: XBRL DOCUMENT v3.25.0.1
Schedule II (Condensed Statements Of Operations) (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenues:      
Net gains (losses) on financial instruments at fair value and foreign exchange $ (42) $ 4 $ 45
Total revenues 42 [1] 7 [2] 154 [3]
Expenses:      
Interest 208 210 179
Provision (benefit) for income taxes 0 0 1
Net income (loss) (447) (491) (195)
Parent Company [Member]      
Revenues:      
Net investment income 27 21 20
Net realized investment gains (losses) 0 (32) (10)
Net gains (losses) on financial instruments at fair value and foreign exchange 8 4 110
Other net realized gains (losses) 2 1 5
Total revenues 37 (6) 125
Expenses:      
Operating 13 15 11
Interest 72 76 76
Total expenses 85 91 87
Income Loss Before Income Taxes And Equity In Earnings Of Subsidiaries, Total (48) (97) 38
Provision (benefit) for income taxes (2) (1) (3)
Income Loss Before Equity In Earnings Of Subsidiaries, Total (46) (96) 41
Equity in net income (loss) of subsidiaries (401) (395) (236)
Net income (loss) $ (447) $ (491) $ (195)
[1] Includes net investment income of $67 million, $30 million, $11 million, and ($24) million for the U.S. Public Finance, Corporate, International and Structured Finance, and Eliminations segments, respectively.
[2] Includes net investment income of $93 million, $25 million, $23 million, and ($25) million for the U.S. Public Finance, Corporate, International and Structured Finance, and Eliminations segments, respectively.
[3] Includes net investment income of $81 million, $22 million, $17 million, and ($25) million for the U.S. Public Finance, Corporate, International and Structured Finance, and Eliminations segments, respectively.